- Embraer ERJ family - Wikipedia
Embraer prioritised the rapid expansion of the family, leading to the introduction of the shortened ERJ 135 and ERJ 140 in 1999 The ERJ series' primary competition came from the similarly sized Bombardier CRJ100 200 regional jets
- European Respiratory Journal | European Respiratory Society
European Respiratory Journal Highlights from the latest issue of the ERJ as chosen by Chief Editor and Deputy Chief Editor James D Chalmers and Don D Sin
- ERJ Range - Commercial Aviation - Embraer
Discover the Embraer ERJ, a reliable and versatile aircraft with over 26 million recorded flight hours Learn about its features, range, and support services, including optimized maintenance and flight safety training
- Embraer-Empresa Brasileira de Aeronautica (ERJ) Stock Price . . .
Embraer S A (NYSE:ERJ), legally known as Embraer – Empresa Brasileira de Aeronáutica S A , is a global aerospace company headquartered in São José dos Campos, Brazil The company designs, develops, manufactures and sells commercial, executive, defence and agricultural aircraft
- The Definitive Guide to the Embraer ERJ Family of Aircraft
The Embraer ERJ family are regional jets produced by the Brazilian aerospace company Embraer The family includes the 37 seat ERJ-135, the 44 seat ERJ-140, the 50 seat ERJ-145, the Legacy 600 series business jet, and the R-99 series of military aircraft
- Embraer ERJ 145 - History, Technical Data Photos - Aero Corner
Development of the ERJ 145 began in 1995, and the aircraft was first certified in 1996 It entered service later in the year and is currently operational around the world
- Embraer ERJ Jet Family: Soaring High in Regional Aviation
For over five decades, the Embraer ERJ (Embraer Regional Jet) family has dominated the skies, revolutionizing regional travel Let’s explore why these jets continue to be a symbol of excellence in the aviation industry
- ERJ Open Research | European Respiratory Society
Elexacaftor tezacaftor ivacaftor (ETI) have been introduced as causal therapy for people with cystic fibrosis (pwCF) carrying at least one F508del allele The real-world effect of ETI in pwCF without any F508del allele is limited
|